AbstractHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020Population Pharmacokinetics of HIV-specific Broadly Monoclonal Neutralizing Long-acting Antibody, VRC01LS, in Term InfantsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020Time Course of Tenofovir-Diphosphate Carryover in DBS Following TDF to TAF SwitchView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020Plasma and Breastmilk Pharmacokinectics of Tenofovir Using Dried Blood and Breast Milk Spots in HIV Infected Postpartum Women in UgandaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020Steady-State Plasma Tfv/FTC Among Adolescent Transgender Men and Women Receiving Directly Observed Daily Tdf/FtcView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020Review on drug interactions of ART and tuberculosis medicationsView Abstract
AbstractHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020Comparative analysis of vaginal microbiota sampling using the menstrual cups and high vaginal swabs in HIV-1 infected pregnant womenView Abstract
AbstractHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020A FAST FORWARD INVESTIGATIVE FORECASTING: Challenges, Unmet Needs and Gaps of the New HIV Prevention Technologies (NPT) in a Malawian ContextView Abstract
AbstractHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020Alteration of the gut fecal microbiome in HIV infected children on anti-retroviral therapy in Yaounde, CameroonView Abstract
AbstractHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020Baseline gut microbiome dysbiosis predicts gut microbiome response to ART/co-trimoxazole treatment in HIV-positive individuals in rural and urban ZimbabweView Abstract
AbstractHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020Impact of contraceptive use on vaginal microbiome in adolescent girlsView Abstract
AbstractHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020LACTIN-V Treatment for Recurrent Bacterial VaginosisView Abstract
AbstractHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020Mosquito borne parasites in patients newly infected with HIV in relationship with CD4 count and TNFαView Abstract
